<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>61(1)</volume><submitter>Qin X</submitter><funding>Natural Science Foundation of Anhui Province</funding><funding>National Natural Science Foundation of China</funding><funding>Clinical Scientific Research Project of the First Affiliated Hospital of Anhui University of Chinese Medicine</funding><funding>Postgraduate scientific research project of Anhui University</funding><pubmed_abstract>&lt;h4>Context&lt;/h4>Qi Teng Xiao Zhuo granule (QTXZG) is a traditional Chinese medicine (TCM) used for therapeutic effects on chronic glomerulonephritis (CGN). However, the underlying mechanism remains unclear.&lt;h4>Objective&lt;/h4>To investigate the molecular mechanism of QTXZG on CGN by proteomics.&lt;h4>Materials and methods&lt;/h4>The CGN model was induced in Sprague-Dawley rats by injecting adriamycin (3.5 mg/kg, Day 1; 3.0 mg/kg, Day 14) twice through the tail vein. Urine samples were collected on the 21&lt;sup>st&lt;/sup> day; and the rats divided randomly into control, adriamycin, QTXZG administration groups. Rats in the QTXZG group received QTXZG (10.8 g/kg); control and adriamycin groups were given physiological saline once per day for 30 days. Proteomics was applied to identify the candidate protei</pubmed_abstract><journal>Pharmaceutical biology</journal><pagination>1120-1134</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10364565</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis.</pubmed_title><pmcid>PMC10364565</pmcid><pubmed_authors>Qin X</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Xu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis.</name><description>&lt;h4>Context&lt;/h4>Qi Teng Xiao Zhuo granule (QTXZG) is a traditional Chinese medicine (TCM) used for therapeutic effects on chronic glomerulonephritis (CGN). However, the underlying mechanism remains unclear.&lt;h4>Objective&lt;/h4>To investigate the molecular mechanism of QTXZG on CGN by proteomics.&lt;h4>Materials and methods&lt;/h4>The CGN model was induced in Sprague-Dawley rats by injecting adriamycin (3.5 mg/kg, Day 1; 3.0 mg/kg, Day 14) twice through the tail vein. Urine samples were collected on the 21&lt;sup>st&lt;/sup> day; and the rats divided randomly into control, adriamycin, QTXZG administration groups. Rats in the QTXZG group received QTXZG (10.8 g/kg); control and adriamycin groups were given physiological saline once per day for 30 days. Proteomics was applied to identify the candidate protei</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-05T07:25:13.218Z</modification><creation>2024-11-13T21:42:41.54Z</creation></dates><accession>S-EPMC10364565</accession><cross_references><pubmed>37477949</pubmed><doi>10.1080/13880209.2023.2233998</doi></cross_references></HashMap>